TY - JOUR AU - Ribas, A. AU - Wolchok, J. D. PY - 2018 DA - 2018// TI - Cancer immunotherapy using checkpoint blockade JO - Science. VL - 359 UR - https://doi.org/10.1126/science.aar4060 DO - 10.1126/science.aar4060 ID - Ribas2018 ER - TY - JOUR AU - McKinney, E. F. AU - Lee, J. C. AU - Jayne, D. R. AU - Lyons, P. A. AU - Smith, K. G. PY - 2015 DA - 2015// TI - T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection JO - Nature. VL - 523 UR - https://doi.org/10.1038/nature14468 DO - 10.1038/nature14468 ID - McKinney2015 ER - TY - JOUR AU - Zinzani, P. L. AU - Ribrag, V. AU - Moskowitz, C. H. AU - Michot, J. M. AU - Kuruvilla, J. AU - Balakumaran, A. PY - 2017 DA - 2017// TI - Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma JO - Blood. VL - 130 UR - https://doi.org/10.1182/blood-2016-12-758383 DO - 10.1182/blood-2016-12-758383 ID - Zinzani2017 ER - TY - JOUR AU - Osta, B. AU - Hu, F. AU - Sadek, R. AU - Chintalapally, R. AU - Tang, S. C. PY - 2017 DA - 2017// TI - Not all immune-checkpoint inhibitors are created equal: meta-analysis and systematic review of immune-related adverse events in cancer trials JO - Crit Rev Oncol Hematol VL - 119 UR - https://doi.org/10.1016/j.critrevonc.2017.09.002 DO - 10.1016/j.critrevonc.2017.09.002 ID - Osta2017 ER - TY - JOUR AU - Schildberg, F. A. AU - Klein, S. R. AU - Freeman, G. J. AU - Sharpe, A. H. PY - 2016 DA - 2016// TI - Coinhibitory pathways in the B7-CD28 ligand-receptor family JO - Immunity. VL - 44 UR - https://doi.org/10.1016/j.immuni.2016.05.002 DO - 10.1016/j.immuni.2016.05.002 ID - Schildberg2016 ER - TY - JOUR AU - Das, R. AU - Bar, N. AU - Ferreira, M. AU - Newman, A. M. AU - Zhang, L. AU - Bailur, J. K. PY - 2018 DA - 2018// TI - Early B cell changes predict autoimmunity following combination immune checkpoint blockade JO - J Clin Invest VL - 128 UR - https://doi.org/10.1172/JCI96798 DO - 10.1172/JCI96798 ID - Das2018 ER - TY - JOUR AU - Kao, J. C. AU - Brickshawana, A. AU - Liewluck, T. PY - 2018 DA - 2018// TI - Neuromuscular complications of programmed cell Death-1 (PD-1) inhibitors JO - Curr Neurol Neurosci Rep VL - 18 UR - https://doi.org/10.1007/s11910-018-0878-7 DO - 10.1007/s11910-018-0878-7 ID - Kao2018 ER - TY - JOUR AU - Dalakas, M. C. PY - 2018 DA - 2018// TI - Neurological complications of immune checkpoint inhibitors: what happens when you 'take the brakes off' the immune system JO - Ther Adv Neurol Disord VL - 11 ID - Dalakas2018 ER - TY - JOUR AU - Venetsanaki, V. AU - Boutis, A. AU - Chrisoulidou, A. AU - Papakotoulas, P. PY - 2019 DA - 2019// TI - Diabetes mellitus secondary to treatment with immune checkpoint inhibitors JO - Curr Oncol VL - 26 UR - https://doi.org/10.3747/co.26.4151 DO - 10.3747/co.26.4151 ID - Venetsanaki2019 ER - TY - JOUR AU - Jilaveanu, L. B. AU - Puligandla, M. AU - Weiss, S. A. AU - Wang, X. V. AU - Zito, C. AU - Flaherty, K. T. PY - 2018 DA - 2018// TI - Tumor microvessel density as a prognostic marker in high-risk renal cell carcinoma patients treated on ECOG-ACRIN E2805 JO - Clin Cancer Res VL - 24 UR - https://doi.org/10.1158/1078-0432.CCR-17-1555 DO - 10.1158/1078-0432.CCR-17-1555 ID - Jilaveanu2018 ER - TY - JOUR AU - Wang, J. AU - Perry, C. J. AU - Meeth, K. AU - Thakral, D. AU - Damsky, W. AU - Micevic, G. PY - 2017 DA - 2017// TI - UV-induced somatic mutations elicit a functional T cell response in the YUMMER1.7 mouse melanoma model JO - Pigment Cell Melanoma Res VL - 30 UR - https://doi.org/10.1111/pcmr.12591 DO - 10.1111/pcmr.12591 ID - Wang2017 ER - TY - JOUR AU - Tan, M. H. AU - Holyoke, E. D. AU - Goldrosen, M. H. PY - 1976 DA - 1976// TI - Murine colon adenocarcinomas: methods for selective culture in vitro JO - J Natl Cancer Inst VL - 56 UR - https://doi.org/10.1093/jnci/56.4.871 DO - 10.1093/jnci/56.4.871 ID - Tan1976 ER - TY - JOUR AU - Zippelius, A. AU - Schreiner, J. AU - Herzig, P. AU - Muller, P. PY - 2015 DA - 2015// TI - Induced PD-L1 expression mediates acquired resistance to agonistic anti-CD40 treatment JO - Cancer Immunol Res VL - 3 UR - https://doi.org/10.1158/2326-6066.CIR-14-0226 DO - 10.1158/2326-6066.CIR-14-0226 ID - Zippelius2015 ER - TY - JOUR AU - Bekar, K. W. AU - Owen, T. AU - Dunn, R. AU - Ichikawa, T. AU - Wang, W. AU - Wang, R. PY - 2010 DA - 2010// TI - Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus JO - Arthritis Rheum VL - 62 UR - https://doi.org/10.1002/art.27515 DO - 10.1002/art.27515 ID - Bekar2010 ER - TY - JOUR AU - Ahmed, K. A. AU - Wang, L. AU - Munegowda, M. A. AU - Mulligan, S. J. AU - Gordon, J. R. AU - Griebel, P. PY - 2012 DA - 2012// TI - Direct in vivo evidence of CD4+ T cell requirement for CTL response and memory via pMHC-I targeting and CD40L signaling JO - J Leukoc Biol VL - 92 UR - https://doi.org/10.1189/jlb.1211631 DO - 10.1189/jlb.1211631 ID - Ahmed2012 ER - TY - JOUR AU - Qian, J. AU - Zheng, Y. AU - Zheng, C. AU - Wang, L. AU - Qin, H. AU - Hong, S. PY - 2012 DA - 2012// TI - Active vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myeloma JO - Blood. VL - 119 UR - https://doi.org/10.1182/blood-2011-07-368472 DO - 10.1182/blood-2011-07-368472 ID - Qian2012 ER - TY - JOUR AU - Kitamura, D. AU - Roes, J. AU - Kuhn, R. AU - Rajewsky, K. PY - 1991 DA - 1991// TI - A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene JO - Nature. VL - 350 UR - https://doi.org/10.1038/350423a0 DO - 10.1038/350423a0 ID - Kitamura1991 ER - TY - JOUR AU - Yuan, J. AU - Adamow, M. AU - Ginsberg, B. A. AU - Rasalan, T. S. AU - Ritter, E. AU - Gallardo, H. F. PY - 2011 DA - 2011// TI - Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab JO - Proc Natl Acad Sci U S A VL - 108 UR - https://doi.org/10.1073/pnas.1110814108 DO - 10.1073/pnas.1110814108 ID - Yuan2011 ER - TY - JOUR AU - Marco, H. AU - Smith, R. M. AU - Jones, R. B. AU - Guerry, M. J. AU - Catapano, F. AU - Burns, S. PY - 2014 DA - 2014// TI - The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease JO - BMC Musculoskelet Disord VL - 15 UR - https://doi.org/10.1186/1471-2474-15-178 DO - 10.1186/1471-2474-15-178 ID - Marco2014 ER - TY - JOUR AU - Shalapour, S. AU - Font-Burgada, J. AU - Caro, G. AU - Zhong, Z. AU - Sanchez-Lopez, E. AU - Dhar, D. PY - 2015 DA - 2015// TI - Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy JO - Nature. VL - 521 UR - https://doi.org/10.1038/nature14395 DO - 10.1038/nature14395 ID - Shalapour2015 ER - TY - JOUR AU - Affara, N. I. AU - Ruffell, B. AU - Medler, T. R. AU - Gunderson, A. J. AU - Johansson, M. AU - Bornstein, S. PY - 2014 DA - 2014// TI - B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas JO - Cancer Cell VL - 25 UR - https://doi.org/10.1016/j.ccr.2014.04.026 DO - 10.1016/j.ccr.2014.04.026 ID - Affara2014 ER - TY - JOUR AU - Somasundaram, R. AU - Zhang, G. AU - Fukunaga-Kalabis, M. AU - Perego, M. AU - Krepler, C. AU - Xu, X. PY - 2017 DA - 2017// TI - Tumor-associated B-cells induce tumor heterogeneity and therapy resistance JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/s41467-017-00452-4 DO - 10.1038/s41467-017-00452-4 ID - Somasundaram2017 ER - TY - JOUR AU - Xiao, X. AU - Lao, X. M. AU - Chen, M. M. AU - Liu, R. X. AU - Wei, Y. AU - Ouyang, F. Z. PY - 2016 DA - 2016// TI - PD-1hi identifies a novel regulatory B-cell population in human Hepatoma that promotes disease progression JO - Cancer Discov VL - 6 UR - https://doi.org/10.1158/2159-8290.CD-15-1408 DO - 10.1158/2159-8290.CD-15-1408 ID - Xiao2016 ER - TY - JOUR AU - Ghosh, S. AU - Hoselton, S. A. AU - Schuh, J. M. PY - 2012 DA - 2012// TI - Mu-chain-deficient mice possess B-1 cells and produce IgG and IgE, but not IgA, following systemic sensitization and inhalational challenge in a fungal asthma model JO - J Immunol VL - 189 UR - https://doi.org/10.4049/jimmunol.1200138 DO - 10.4049/jimmunol.1200138 ID - Ghosh2012 ER - TY - JOUR AU - Johnson, D. B. AU - Sullivan, R. J. AU - Ott, P. A. AU - Carlino, M. S. AU - Khushalani, N. I. AU - Ye, F. PY - 2016 DA - 2016// TI - Ipilimumab therapy in patients with advanced melanoma and preexisting autoimmune disorders JO - JAMA Oncol VL - 2 UR - https://doi.org/10.1001/jamaoncol.2015.4368 DO - 10.1001/jamaoncol.2015.4368 ID - Johnson2016 ER - TY - JOUR AU - Johnson, D. B. AU - Balko, J. M. AU - Compton, M. L. AU - Chalkias, S. AU - Gorham, J. AU - Xu, Y. PY - 2016 DA - 2016// TI - Fulminant myocarditis with combination immune checkpoint blockade JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1609214 DO - 10.1056/NEJMoa1609214 ID - Johnson2016 ER - TY - JOUR AU - Shiuan, E. AU - Beckermann, K. E. AU - Ozgun, A. AU - Kelly, C. AU - McKean, M. AU - McQuade, J. PY - 2017 DA - 2017// TI - Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy JO - J Immunother Cancer VL - 5 UR - https://doi.org/10.1186/s40425-017-0210-0 DO - 10.1186/s40425-017-0210-0 ID - Shiuan2017 ER - TY - JOUR AU - Siegel, J. a. c. o. b. AU - Totonchy, M. a. r. i. a. m. AU - Damsky, W. i. l. l. i. a. m. AU - Berk-Krauss, J. u. l. i. a. n. a. AU - Castiglione, F. r. a. n. k. AU - Sznol, M. a. r. i. o. AU - Petrylak, D. a. n. i. e. l. P. AU - Fischbach, N. e. a. l. AU - Goldberg, S. a. r. a. h. B. AU - Decker, R. o. y. H. AU - Stamatouli, A. n. g. e. l. i. k. i. M. AU - Hafez, N. a. v. i. d. AU - Glusac, E. a. r. l. J. AU - Tomayko, M. a. r. y. M. AU - Leventhal, J. o. n. a. t. h. a. n. S. PY - 2018 DA - 2018// TI - Bullous disorders associated with anti–PD-1 and anti–PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy JO - Journal of the American Academy of Dermatology VL - 79 UR - https://doi.org/10.1016/j.jaad.2018.07.008 DO - 10.1016/j.jaad.2018.07.008 ID - Siegel2018 ER -